| P2093 | author name string | Maini RN | |
| | Williams RO | |
| | Feldmann M | |
| | Mason LJ | |
| P2860 | cites work | Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis | Q24564656 |
| | Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms. | Q34515456 |
| | Management of early inflammatory arthritis. Intervention with immunomodulatory agents: monoclonal antibody therapy | Q35838765 |
| | TNF alpha--a pivotal role in rheumatoid arthritis? | Q36092239 |
| | Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 | Q36350833 |
| | Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 |
| | Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice | Q37147228 |
| | Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis | Q37253521 |
| | Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor | Q37558444 |
| | New therapeutic approaches in rheumatoid arthritis. | Q38365057 |
| | Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities | Q39507424 |
| | Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG | Q40699364 |
| | Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis | Q41106185 |
| | Induction of tolerance by monoclonal antibody therapy | Q43419298 |
| | Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis | Q44064388 |
| | Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody | Q44470896 |
| | Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels | Q46347384 |
| | The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis | Q47569532 |
| | Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin | Q53804393 |
| | Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair | Q53899706 |
| | Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis | Q54273412 |
| | Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. | Q54729757 |
| | Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. | Q54784059 |
| | Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α | Q56813295 |
| | Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen | Q57352355 |
| | Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage | Q59063497 |
| | Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo | Q59082223 |
| | CD4 monoclonal antibody pairs for immunosuppression and tolerance induction | Q61651783 |
| | Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor | Q67869949 |
| | Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha | Q68007091 |
| | Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis | Q68028260 |
| | The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities | Q68094969 |
| | In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice | Q68095946 |
| | Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta | Q68223818 |
| | Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor | Q68827373 |
| | Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice | Q69205646 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2762-2766 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis | |
| P478 | volume | 91 | |